Evaluation of Gait Performance in Children With Neuromuscular Diagnoses
Evaluation of the Gait Performance Measures 'Functional Mobility Scale' and 'Gillette Functional Assessment Questionnaire' in Children With Neuromuscular Diagnoses
1 other identifier
observational
72
1 country
1
Brief Summary
The aims of this project are to evaluate the psychometric properties of the German versions of the two performance questionnaires 'Functional Mobility Scale' (FMS) and 'Gillette Functional Assessment Questionnaire - walking scale' (GFAQ) in children between 6-18 years with a neuromuscular diagnosis.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2014
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2014
CompletedFirst Submitted
Initial submission to the registry
September 1, 2014
CompletedFirst Posted
Study publicly available on registry
September 11, 2014
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 31, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
January 31, 2016
CompletedNovember 5, 2020
November 1, 2020
1.8 years
September 1, 2014
November 4, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Functional Mobility Scale (FMS)
The questionnaire is filled in independently by the parents, the primary nurse as well as the physiotherapist of each child.
Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with measurements at admission and discharge.
Gillette Functional Assessment Questionnaire - Walking Scale (GFAQ)
The questionnaire is filled in independently by the parents, the primary nurse as well as the physiotherapist of each child.
Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with measurements at admission and discharge.
Secondary Outcomes (1)
Global Rating Scale (GRS)
Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with only one measurement at discharge.
Other Outcomes (3)
Functional Independence Measure for Children (WeeFIM)
Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with measurements at admission and discharge.
10-Meter Walk Test (10MWT)
Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with only one measurement at discharge.
6-Minute walk test (6MinWT)
Participants will be followed for the duration of the rehabilitation stay, an expected average of 12 weeks, with only one measurement at discharge.
Study Arms (1)
Gait rehabilitation
Multi-modal therapy program including physiotherapy with the aim of gait improvement, Lokomat or treadmill training, strength training, sports therapy. Frequency and intensity are individually assigned.
Interventions
Eligibility Criteria
Children with neuromuscular diagnoses, who are inpatients in the rehabilitation center of the University Children's Hospital Zurich in Affoltern am Albis.
You may qualify if:
- Neuromuscular diagnosis
- Age: 6-18 years
- Rehabilitation goal = improvement of walking abilities
You may not qualify if:
- Children's whose parents are not German-speaking
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
University Children's Hospital Zurich, Rehabilitation Center
Affoltern am Albis, CH-8910, Switzerland
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Corinne Ammann-Reiffer, MPTSc
University Children's Hospital Zurich, Rehabilitation Center Affoltern
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 1, 2014
First Posted
September 11, 2014
Study Start
April 1, 2014
Primary Completion
January 31, 2016
Study Completion
January 31, 2016
Last Updated
November 5, 2020
Record last verified: 2020-11